Giselle Sholler, MD
Beat Childhood Cancer at Penn State University · Beat Childhood Cancer · Beat Childhood Cancer at Atrium Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Giselle Sholler, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:38 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04837547 · PEACH TRIAL- Precision Medicine and Adoptive Cellular TherapyUniversity of Florida · recruiting · Neuroblastoma, Diffuse Intrinsic Pontine Glioma · study chair
- N/ANCT04715178 · Beat Childhood Cancer Specimen Banking and Data RegistryGiselle Sholler · recruiting · Pediatric Cancer, Survivorship · study chair
- Ph2NCT04301843 · Eflornithine (DFMO) and Etoposide for Relapsed/Refractory NeuroblastomaGiselle Sholler · active not recruiting · Neuroblastoma · study chair
- N/ANCT03581240 · An Intermediate Expanded Use Trial of DFMOGiselle Sholler · available · Neuroblastoma, Medulloblastoma, Typical Teratoid Rhabdoid Tumor · study chair
- Ph2NCT02679144 · Neuroblastoma Maintenance Therapy TrialGiselle Sholler · active not recruiting · Neuroblastoma · study chair
- Ph2NCT02559778 · Pediatric Precision Laboratory Advanced Neuroblastoma TherapyGiselle Sholler · recruiting · Neuroblastoma · study chair
- N/ANCT02162732 · Molecular-Guided Therapy for Childhood CancerGiselle Sholler · completed · Neuroblastoma, Medulloblastoma, Glioma · study chair
- N/ANCT01802567 · Molecular-Guided Therapy for Relapsed and Refractory Childhood CancerGiselle Sholler · completed · Neuroblastoma, Medulloblastoma, Brain Tumors · study chair
- Ph2NCT01774253 · Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine GliomaGiselle Sholler · terminated · Pontine Glioma · study chair
- Ph1/Ph2NCT01483820 · Safety and Efficacy Study of TPI-287 in Neuroblastoma and MedulloblastomaGiselle Sholler · terminated · Neuroblastoma, Medulloblastoma · principal investigator
- N/ANCT01355679 · Molecular Guided Therapy for Refractory or Recurrent NeuroblastomaGiselle Sholler · completed · Neuroblastoma · study chair
- N/ANCT01109238 · A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent NeuroblastomaGiselle Sholler · completed · Refractory Neuroblastoma, Relapsed Neuroblastoma · study chair
- Ph1NCT01059071 · Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With EtoposideGiselle Sholler · completed · Neuroblastoma · study chair
- Ph1NCT00867568 · TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or MedulloblastomaGiselle Sholler · completed · Neuroblastoma, Medulloblastoma, Relapse · study chair
- Ph2NCT00601003 · Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or MedulloblastomaGiselle Sholler · completed · Neuroblastoma, Medulloblastoma · study chair
- Ph1NCT00486564 · Safety Study of Nifurtimox for Relapsed or Refractory NeuroblastomaUniversity of Vermont · completed · Neuroblastoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in neuroblastoma.